Related Experiment Videos
Caspase activity is required for commitment to Fas-mediated apoptosis
1Department of Biological Sciences, Keele University, Staffordshire, UK.
The EMBO Journal
|July 1, 1997
Summary
Inhibiting certain caspases (cysteine aspartate-specific proteases) protected human T cells from apoptosis, suggesting their role in diseases and potential as therapeutic targets.
Area of Science:
- Biomedical Sciences
- Cell Biology
- Molecular Biology
Background:
- Apoptosis (programmed cell death) is crucial in biology but its mechanisms are not fully understood.
- The Interleukin-1beta Converting Enzyme (ICE) family, now known as caspases, are key proteases involved in apoptosis.
- Caspase dysfunction is implicated in diseases where apoptosis fails or occurs inappropriately.
Purpose of the Study:
- To investigate the role of caspases in mammalian cell death.
- To determine if inhibiting caspases can prevent apoptosis in human T cells.
- To assess the therapeutic potential of targeting caspases.
Main Methods:
- Used peptide inhibitors and crmA transfection to inhibit caspases in intact human T cells (Jurkat and CEM-C7).
- Assessed cell survival using a colony-forming assay after Fas-induced apoptosis.
- Examined the effect of selective caspase inhibition on apoptosis.
Main Results:
- Selective inhibition of specific caspases significantly protected human T cells from Fas-induced apoptosis.
- Cell survival increased dramatically (up to 320-fold) in treated cells.
- This indicates that caspase activity is required for commitment to cell death.
Conclusions:
- Caspase activity is essential for Fas-induced apoptosis in human T cells.
- Dysfunction of certain caspases may contribute to cancer and autoimmune diseases.
- Caspases represent promising molecular targets for therapeutic intervention in degenerative diseases and conditions involving inappropriate apoptosis.